Sinopharm's 2024 Attributable Profit Slides; Shares Fall 4%

MT Newswires Live

03-24

Sinopharm (HKG:1099) attributable profit fell to 7.05 billion yuan in 2024 from 9.05 billion yuan in 2023, according to a Monday filing with the Hong Kong bourse.

Earnings per share at the pharmaceutical company decreased to 2.26 yuan from 2.90 yuan a year earlier. Analysts at Visible Alpha estimated EPS at 2.67 yuan.

Revenue declined to 584.5 billion yuan from 596.6 billion yuan in the previous year. Visible Alpha analysts forecast revenue at 600.1 billion yuan.

The company declared a final dividend of 0.68 yuan per share, payable Aug. 12 to shareholders on record as of June 23.

Shares slipped 4% during Monday's afternoon trading.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2521676848"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2521676848\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2521676848?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-24 14:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2521676848","market":"nz","top_or_hot":-1,"title":"Sinopharm's 2024 Attributable Profit Slides; Shares Fall 4%","media":"MT Newswires Live","content":"<html><body><p> Sinopharm (HKG:1099) attributable profit fell to 7.05 billion yuan in 2024 from 9.05 billion yuan in 2023, according to a Monday filing with the Hong Kong bourse.</p><p>Earnings per share at the pharmaceutical company decreased to 2.26 yuan from 2.90 yuan a year earlier.  Analysts at Visible Alpha estimated EPS at 2.67 yuan.</p><p>Revenue declined to 584.5 billion yuan from 596.6 billion yuan in the previous year. Visible Alpha analysts forecast revenue at 600.1 billion yuan.</p><p>The company declared a final dividend of 0.68 yuan per share, payable Aug. 12 to shareholders on record as of June 23.</p><p>Shares slipped 4% during Monday's afternoon trading.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinopharm's 2024 Attributable Profit Slides; Shares Fall 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinopharm's 2024 Attributable Profit Slides; Shares Fall 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-24 14:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Sinopharm (HKG:1099) attributable profit fell to 7.05 billion yuan in 2024 from 9.05 billion yuan in 2023, according to a Monday filing with the Hong Kong bourse.</p><p>Earnings per share at the pharmaceutical company decreased to 2.26 yuan from 2.90 yuan a year earlier.  Analysts at Visible Alpha estimated EPS at 2.67 yuan.</p><p>Revenue declined to 584.5 billion yuan from 596.6 billion yuan in the previous year. Visible Alpha analysts forecast revenue at 600.1 billion yuan.</p><p>The company declared a final dividend of 0.68 yuan per share, payable Aug. 12 to shareholders on record as of June 23.</p><p>Shares slipped 4% during Monday's afternoon trading.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1197","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2521676848","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2521676848","pubTimestamp":1742796050,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Sinopharm  attributable profit fell to 7.05 billion yuan in 2024 from 9.05 billion yuan in 2023, according to a Monday filing with the Hong Kong bourse.Earnings per share at the pharmaceutical company decreased to 2.26 yuan from 2.90 yuan a year earlier.  Analysts at Visible Alpha estimated EPS at 2.67 yuan.Revenue declined to 584.5 billion yuan from 596.6 billion yuan in the previous year. Visible Alpha analysts forecast revenue at 600.1 billion yuan.The company declared a final dividend of 0.68 yuan per share, payable Aug. 12 to shareholders on record as of June 23.Shares slipped 4% during Monday's afternoon trading.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1197":"保健护理产品经销商","LU0640798160.USD":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","BK1515":"抗疫概念","BK1500":"做空集合股","01099":"国药控股"},"translate_title":"国药控股2024年归属利润下滑；股价下跌4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"Sinopharm (HKG:1099) attributable profit fell to 7.05 billion yuan in 2024 from 9.05 billion yuan in 2023, according to a Monday filing with the Hong Kong bourse.Earnings per share at the pharmaceutical company decreased to 2.26 yuan from 2.90 yuan a year earlier.  Analysts at Visible Alpha estimated EPS at 2.67 yuan.Revenue declined to 584.5 billion yuan from 596.6 billion yuan in the previous year. Visible Alpha analysts forecast revenue at 600.1 billion yuan.The company declared a final dividend of 0.68 yuan per share, payable Aug. 12 to shareholders on record as of June 23.Shares slipped 4% during Monday's afternoon trading.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}